Lipid-lowering therapy modification and LDL-C Goal achievement after an acute coronary syndrome: a prospective Swiss cohort

被引：0
|
作者：
Gencer, B. [1 ]
Mach, F. [1 ]
Auer, R. [2 ]
Raeber, L. [3 ]
Nanchen, D. [4 ]
Meyer, P. [1 ]
Matter, C. M. [5 ]
Windecker, S. [3 ]
Luescher, T. F. [5 ]
Rodondi, N. [6 ]
机构：
[1] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland
[4] PMU, Lausanne, Switzerland
[5] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland
[6] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [1] Lipid-lowering Therapy and LDL Cholesterol in Patients after acute Coronary Syndrome
    Haider, P.
    Galli, L.
    Schrutka, L.
    Distelmaier, K.
    Wojta, J.
    Hengstenberg, C.
    Krychtiuk, K.
    Speidl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S419 - S419
  • [2] LDL-C goal achievement and lipid-lowering therapy in patients by atherosclerotic cardiovascular disease subtype: the SANTORINI study
    Catapano, A. L.
    Manu, M. C.
    Burden, A.
    Ray, K. K.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2373 - 2373
  • [3] Lipid-Lowering Therapy after Acute Coronary Syndrome
    Pogran, Edita
    Burger, Achim Leo
    Zweiker, David
    Kaufmann, Christoph Clemens
    Muthspiel, Marie
    Rega-Kaun, Gersina
    Wenkstetten-Holub, Alfa
    Wojta, Johann
    Drexel, Heinz
    Huber, Kurt
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [4] THE EFFECT OF AN INTENSIVE LIPID-LOWERING THERAPY PROTOCOL ON ACHIEVING TARGET LDL-C LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Seiyama, Kosuke
    Oka, Akihiro
    Takagi, Wataru
    Okada, Tomoaki
    Nosaka, Kazumasa
    Miyoshi, Toru
    Doi, Masayuki
    ATHEROSCLEROSIS, 2024, 395
  • [5] Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
    Zhang, Shuang
    Li, Zhi-Fan
    Shi, Hui-Wei
    Zhang, Wen-Jia
    Sui, Yong-Gang
    Li, Jian-Jun
    Dou, Ke-Fei
    Qian, Jie
    Wu, Na-Qiong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [6] Lipid-lowering therapy in patients with a 'normal' LDL-C Authors' response
    Nelson, Adam
    Nicholls, Stephen
    AUSTRALIAN PRESCRIBER, 2024, 47 (03) : 94 - 94
  • [7] Lipid-Lowering Therapy after Acute Coronary Syndrome in Outpatient Practice-How to Achieve Goal
    Rajtar-Salwa, Renata
    Bobrowska, Beata
    Batko, Jakub
    Bartus, Stanislaw
    Petkow-Dimitrow, Pawel
    Krawczyk-Ozog, Agata
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [8] Impact of Adherence to Lipid-Lowering Guidelines on the Achievement of Lipid Profile Goals in Patients With Acute Coronary Syndrome: A Prospective Cohort Study
    Camacho-Caballero, Kiara
    Zevallos, Alba
    Chambergo-Michilot, Diego
    Rodriguez-Cuba, Maria A.
    Runzer-Colmenares, Fernando M.
    Aguirre-Zurita, Oscar
    IRANIAN HEART JOURNAL, 2023, 24 (04): : 54 - 62
  • [9] Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial
    Hess, Connie N.
    Daffron, Ashley
    Nehler, Mark R.
    Szarek, Michael
    Cannon, Christopher P.
    Hsia, Judith
    Saseen, Joseph J.
    Bonaca, Marc P.
    VASCULAR MEDICINE, 2025,
  • [10] LDL-C Goal Attainment According to Prescribed Lipid-Lowering Therapy: Results from the LIPIDE European Survey
    Desamericq, Gaelle
    Laforest, Laurent
    Schwalm, Marie-Sophie
    Moulin, Philippe
    Michel, Emilie
    Eteve, Caroline
    Coffin, Gabriel
    Ritleng, Cecile
    Van Ganse, Eric
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S154 - S154
12345